Patents by Inventor Stephen McNERLIN

Stephen McNERLIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190076456
    Abstract: Embodiments of the present invention disclose a composition comprising nicotinamide adenine dinucleotide (NAD+), wherein the NAD+ is in an amount effective for a liver disorder in a mammal. Methods of making and using the invention composition are also disclosed.
    Type: Application
    Filed: September 12, 2017
    Publication date: March 14, 2019
    Inventor: Stephen McNERLIN
  • Publication number: 20190070209
    Abstract: Embodiments of the present invention disclose a composition comprising nicotinamide adenine dinucleotide (NAD+) and optionally a nonsteroidal anti-inflammatory drug (NSAID), wherein the NAD+ is in an amount effective for a condition in a mammal associated with aging. Methods of making and using the invention composition are also disclosed.
    Type: Application
    Filed: September 6, 2017
    Publication date: March 7, 2019
    Inventor: Stephen McNERLIN
  • Publication number: 20190070210
    Abstract: Embodiments of the present invention disclose a composition comprising nicotinamide adenine dinucleotide (NAD+) and optionally a nonsteroidal anti-inflammatory drug (NSAID), wherein the NAD+is in an amount effective for a condition in a mammal associated with aging. Methods of making and using the invention composition are also disclosed.
    Type: Application
    Filed: September 13, 2017
    Publication date: March 7, 2019
    Inventor: Stephen McNERLIN